These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7608491)

  • 1. Basal core-IgM antibodies to hepatitis C virus are not predictive of successful alpha-interferon therapy.
    Caporaso N; Tuccillo C; Morisco F
    J Hepatol; 1995 Mar; 22(3):377. PubMed ID: 7608491
    [No Abstract]   [Full Text] [Related]  

  • 2. Early prediction of successful alpha-interferon therapy of chronic hepatitis C by core-IgM antibodies to hepatitis C virus.
    Tassopoulos NC; Hatzakis AE; Papatheodoridis GV; Karvountzis G; Troonen H; Lennartz L
    J Hepatol; 1994 Feb; 20(2):305-6. PubMed ID: 7516362
    [No Abstract]   [Full Text] [Related]  

  • 3. Are basal core-IgM antibodies to hepatitis C virus predictive of successful alpha-interferon therapy?
    Pawlotsky JM; Roudot-Thoraval F; Bastie A; Duval J; Dhumeaux D
    J Hepatol; 1995 Dec; 23(6):760-1. PubMed ID: 8750179
    [No Abstract]   [Full Text] [Related]  

  • 4. The significance of immunoglobulin M antibody response to hepatitis C virus core protein in patients with chronic hepatitis C.
    Yuki N; Hayashi N; Ohkawa K; Hagiwara H; Oshita M; Katayama K; Sasaki Y; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1995 Aug; 22(2):402-6. PubMed ID: 7543432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up study of serum IgM antibody to hepatitis C virus (HCV), HCV replication, and liver disease outcome in chronic hepatitis C.
    Quiroga JA; Herrero M; Castillo I; Navas S; Pardo M; Carreño V
    J Infect Dis; 1994 Sep; 170(3):669-73. PubMed ID: 7521377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-hepatitis C virus immunoglobulin M antibody in patients with chronic hepatitis type C.
    Kikuchi T; Onji M; Michitaka K; Ohta Y
    Hepatogastroenterology; 1992 Dec; 39(6):525-8. PubMed ID: 1336473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C. Comparison of alanine aminotransferase normalization versus loss of HCV RNA and anti-HCV IgM.
    Douglas DD; Rakela J; Lin HJ; Hollinger FB; Taswell HF; Czaja AJ; Gross JB; Anderson ML; Parent K; Fleming CR
    Dig Dis Sci; 1993 Apr; 38(4):601-7. PubMed ID: 8384978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin M antibody to hepatitis C virus core antigen: correlations with viral replication, histological activity, and liver disease outcome.
    Quiroga JA; van Binsbergen J; Wang CY; Pardo M; Navas S; Trines C; Herrero M; Carreño V
    Hepatology; 1995 Dec; 22(6):1635-40. PubMed ID: 7489967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of IgM antibodies to hepatitis C virus in patients with chronic hepatitis C undergoing interferon-alpha therapy. Analysis by two different methods.
    Torronteras R; Sánchez-Quijano A; Abad MA; Soto B; Andreu J; Medrano FJ; Leal M; Lissen E
    J Viral Hepat; 1994; 1(2):159-61. PubMed ID: 8790572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The quantitative humoral immune response to the hepatitis C virus is correlated with disease activity and response to interferon-alpha.
    Löhr HF; Elste C; Dienes HP; Michel G; Braun HB; Meyer zum Büschenfelde KH; Gerken G
    J Hepatol; 1996 Sep; 25(3):292-300. PubMed ID: 8895007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of anti-hepatitis C virus IgM core antibodies may predict the response to interferon-alpha therapy in chronic hepatitis C.
    Tabone M; Galatola G; Secreto P; Marini C; Molinaro G; Aricò' S
    J Viral Hepat; 1994; 1(2):155-7. PubMed ID: 8790571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in antibodies to specific hepatitis C virus antigens with interferon-alpha therapy: analysis by recombinant immunoblot assay.
    Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
    Am J Gastroenterol; 1993 Jun; 88(6):914-8. PubMed ID: 7684885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin M antibody to hepatitis C virus during interferon therapy for chronic hepatitis C.
    Quiroga JA; Bosch O; Gonzalez R; Marriott E; Castillo I; Bartolome J; Carreño V
    Gastroenterology; 1992 Oct; 103(4):1285-9. PubMed ID: 1383071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detectable levels of IgM antibodies to hepatitis C virus core protein predict breakthrough in patients with chronic hepatitis C treated with interferon-alpha.
    Fracassetti O; Tambini R; Perani V; Vicari O; Lorenzi N; Delvecchio G
    J Viral Hepat; 1996 Sep; 3(5):265-6. PubMed ID: 8914007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis C; current developments in diagnosis and therapy].
    Willems M; Moshage H; Fevery J; Yap SH
    Ned Tijdschr Geneeskd; 1992 Dec; 136(52):2564-7. PubMed ID: 1282675
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy.
    Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1993 Jun; 17(6):960-5. PubMed ID: 7685734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting treatment responses to interferon-alpha in chronic hepatitis C.
    Pawlotsky JM; Roudot-Thoraval F; Bastie A; Darthuy F; Rémiré J; Métreau JM; Zafrani ES; Duval J; Dhumeaux D
    J Infect Dis; 1996 Jul; 174(1):1-7. PubMed ID: 8655978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of serum immunoglobulin M to hepatitis C virus core in patients with chronic hepatitis C.
    Tran A; Yang G; Dreyfus G; Rouquié P; Durant J; Rampal A; Rampal P; Benzaken S
    Am J Gastroenterol; 1997 Oct; 92(10):1835-8. PubMed ID: 9382047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of hepatitis C virus RNA and IgM antibodies to hepatitis C core in chronic hepatitis C.
    Martinelli AL; Brown D; Braun HB; Michel G; Dusheiko GM
    J Hepatol; 1996 Jan; 24(1):21-6. PubMed ID: 8834020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus serotype II responds more favorably to interferon-alpha therapy.
    Orito E; Mizokami M; Mizoguchi N; Ohba K; Tohnai M; Yamanaka H; Oguri T; Hirashima N; Koide T; Kano H
    J Hepatol; 1994 Jul; 21(1):130-2. PubMed ID: 7525694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.